Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study To Evaluate The Performance And Operation Of The Brevera™ Breast Biopsy System

NCT03456583 is registered in ClinicalTrials.gov with Hologic, Inc. as lead sponsor.

NCT NCT03456583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03456583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study To Evaluate The Performance And Operation Of The Brevera™ Breast Biopsy System
Lead sponsor
Hologic, Inc.
Phase
Observational
Overall status
Completed
Start date
November 20, 2017
Completion date
November 20, 2018
Enrollment
500 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female